Overview

Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea Pedis

Status:
Completed

Trial end date:
2004-05-01

Target enrollment:

Participant gender:

Summary

The objectives of this study were to demonstrate comparable safety and efficacy of Ciclopirox Olamine Cream (Test Product) and Ciclopirox Cream 0.77% (Reference Product) in the treatment of subjects with tinea pedis, and to show the superiority of the active treatments over that of the vehicle.

Phase:

Phase 3

Details

Lead Sponsor:

Padagis LLC
Perrigo Company

Treatments:

Ciclopirox